Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.

Benjo AM, El-Hayek GE, Messerli F, DiNicolantonio JJ, Hong MK, Aziz EF, Herzog E, Tamis-Holland JE.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):53-60. doi: 10.1002/ccd.25302. Epub 2013 Dec 21. Review.

PMID:
24272891
2.
3.
4.
6.

Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction.

Norris DM, Anderson JR.

Cardiol Rev. 2012 Nov-Dec;20(6):319-24. doi: 10.1097/CRD.0b013e31826db7ff. Review.

PMID:
22874885
7.

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, Hong MK, Kim BK, Oh SJ, Jeon DW, Yang JY, Cho JR, Lee NH, Cho YH, Cho DK, Jang Y.

JACC Cardiovasc Interv. 2010 Mar;3(3):332-9. doi: 10.1016/j.jcin.2009.11.021. Erratum in: JACC Cardiovasc Interv. 2012 Feb;5(2):248.

8.

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.

Patti G, Cannon CP, Murphy SA, Mega S, Pasceri V, Briguori C, Colombo A, Yun KH, Jeong MH, Kim JS, Choi D, Bozbas H, Kinoshita M, Fukuda K, Jia XW, Hara H, Cay S, Di Sciascio G.

Circulation. 2011 Apr 19;123(15):1622-32. doi: 10.1161/CIRCULATIONAHA.110.002451. Epub 2011 Apr 4.

9.

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.

Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2.

PMID:
22858186
10.

Preloading with atorvastatin before percutaneous coronary intervention in statin-naïve Asian patients with non-ST elevation acute coronary syndromes: A randomized study.

Jang Y, Zhu J, Ge J, Kim YJ, Ji C, Lam W.

J Cardiol. 2014 May;63(5):335-43. doi: 10.1016/j.jjcc.2013.09.012. Epub 2013 Nov 9.

11.

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A.

J Am Coll Cardiol. 2009 Aug 4;54(6):558-65. doi: 10.1016/j.jacc.2009.05.028. Epub 2009 Jul 2.

12.

Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.

Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA.

JACC Cardiovasc Interv. 2013 Aug;6(8):814-23. doi: 10.1016/j.jcin.2013.04.010. Review.

13.

[Prevention of complications after percutaneous coronary interventions with statins].

Mega S, Nusca A, Patti G.

Recenti Prog Med. 2012 Jan;103(1):5-10. doi: 10.1701/1022.11151. Italian.

PMID:
22322620
14.

Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Navarese EP, Kowalewski M, Andreotti F, van Wely M, Camaro C, Kolodziejczak M, Gorny B, Wirianta J, Kubica J, Kelm M, de Boer MJ, Suryapranata H.

Am J Cardiol. 2014 May 15;113(10):1753-64. doi: 10.1016/j.amjcard.2014.02.034. Epub 2014 Mar 2. Review.

PMID:
24792742
15.

Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea.

Kim MJ, Jeon DS, Gwon HC, Kim SJ, Chang K, Kim HS, Tahk SJ; Korean MUSTANG Investigators.

Clin Cardiol. 2012 Nov;35(11):700-6. doi: 10.1002/clc.22038. Epub 2012 Jul 23.

16.

Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.

Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.

Kardiol Pol. 2006 Dec;64(12):1357-62; discussion 1363. English, Polish.

17.

Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.

Toso A, Leoncini M, Maioli M, Gallopin M, Tedeschi D, Amato M, Bellandi F.

J Cardiovasc Med (Hagerstown). 2011 May;12(5):318-21. doi: 10.2459/JCM.0b013e328341024f.

PMID:
21045713
18.

Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.

D'Ascenzo F, Moretti C, Omedè P, Cerrato E, Cavallero E, Er F, Presutti DG, Colombo F, Crimi G, Conrotto F, Dinicolantonio JJ, Chen S, Prasad A, Biondi Zoccai G, Gaita F.

EuroIntervention. 2014;9(12):1463-71. doi: 10.4244/EIJV9I12A244. Review.

19.

Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.

Ebrahimi R, Saleh J, Toggart E, Shah AP, Azmoon S, Babaei H, Lee J, Smith R, Movahed MR, Rubin SA.

J Invasive Cardiol. 2008 Jun;20(6):292-5.

Supplemental Content

Support Center